Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $1.00 per share
-
Shares outstanding
-
7.36M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
2.83M
-
Shares change
-
-278K
-
Total reported value, excl. options
-
$15.5M
-
Value change
-
-$1.83M
-
Number of buys
-
10
-
Number of sells
-
-18
-
Price
-
$5.48
Significant Holders of HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) as of Q2 2023
34 filings reported holding HHS - HARTE HANKS INC - Common Stock, par value $1.00 per share as of Q2 2023.
HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.83M shares
of 7.36M outstanding shares and own 38.41% of the company stock.
Largest 10 shareholders include WESTERLY CAPITAL MANAGEMENT, LLC (715K shares), BLAIR WILLIAM & CO/IL (661K shares), VANGUARD GROUP INC (287K shares), ACADIAN ASSET MANAGEMENT LLC (191K shares), CREDIT SUISSE AG/ (127K shares), Krilogy Financial LLC (91.5K shares), RENAISSANCE TECHNOLOGIES LLC (86K shares), Hillsdale Investment Management Inc. (82.8K shares), GEODE CAPITAL MANAGEMENT, LLC (72.1K shares), and TWO SIGMA ADVISERS, LP (68.1K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.